Sanjay Subramanian Inozyme Pharma, Inc. (INZY) insider trading activity

Sanjay Subramanian is SVP, CFO of Inozyme Pharma, Inc.. Currently has a direct ownership of 30,398 shares of INZY, which is worth approximately $134,359. The most recent transaction as insider was on Sep 29, 2023, when has been sold 2,319 shares (Common Stock) at a price of $3.57 per share, resulting in proceeds of $8,278. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 30.4K

0% 3M change

8.26% 12M change

Total Value Held $134,359

Sanjay Subramanian Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 29 2023	BUY Grant, award, or other acquisition	$8,278 $3.57 p/Share	2,319 Added 7.09%	30,398 Common Stock
Mar 31 2023	BUY Grant, award, or other acquisition	$2,163 $2.21 p/Share	979 Added 3.37%	28,079 Common Stock
Apr 19 2022	BUY Open market or private purchase	$99,999 $3.69 p/Share	27,100 Added 50.0%	27,100 Common Stock

Also insider at

OCGN

Ocugen, Inc. Healthcare

Chief Financial Officer